Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Genes, environment and gene expression in colon tissue: a pathway approach to determining functionality.

Slattery ML, Pellatt DF, Wolff RK, Lundgreen A.

Int J Mol Epidemiol Genet. 2016 Mar 23;7(1):45-57. eCollection 2016.

2.

Red meat, poultry, and fish intake and breast cancer risk among Hispanic and Non-Hispanic white women: The Breast Cancer Health Disparities Study.

Kim AE, Lundgreen A, Wolff RK, Fejerman L, John EM, Torres-Mejía G, Ingles SA, Boone SD, Connor AE, Hines LM, Baumgartner KB, Giuliano A, Joshi AD, Slattery ML, Stern MC.

Cancer Causes Control. 2016 Apr;27(4):527-43. doi: 10.1007/s10552-016-0727-4. Epub 2016 Feb 22.

3.

Energy homeostasis genes and survival after breast cancer diagnosis: the Breast Cancer Health Disparities Study.

Pellatt AJ, Lundgreen A, Wolff RK, Hines L, John EM, Slattery ML.

Cancer Causes Control. 2016 Jan;27(1):47-57.

4.

Energy homeostasis genes and breast cancer risk: The influence of ancestry, body size, and menopausal status, the breast cancer health disparities study.

Slattery ML, Lundgreen A, Hines L, Wolff RK, Torres-Mejia G, Baumgartner KN, John EM.

Cancer Epidemiol. 2015 Dec;39(6):1113-22. doi: 10.1016/j.canep.2015.08.012. Epub 2015 Sep 26.

5.

MAPK genes interact with diet and lifestyle factors to alter risk of breast cancer: the Breast Cancer Health Disparities Study.

Slattery ML, Lundgreen A, John EM, Torres-Mejia G, Hines L, Giuliano AR, Baumgartner KB, Stern MC, Wolff RK.

Nutr Cancer. 2015;67(2):292-304. doi: 10.1080/01635581.2015.990568. Epub 2015 Jan 28.

6.

The influence of the CHIEF pathway on colorectal cancer-specific mortality.

Slattery ML, Lundgreen A.

PLoS One. 2014 Dec 26;9(12):e116169. doi: 10.1371/journal.pone.0116169. eCollection 2014.

7.

Diet and lifestyle factors modify immune/inflammation response genes to alter breast cancer risk and prognosis: the Breast Cancer Health Disparities Study.

Slattery ML, Lundgreen A, Torres-Mejia G, Wolff RK, Hines L, Baumgartner K, John EM.

Mutat Res. 2014 Dec;770:19-28.

8.

A pathway approach to evaluating the association between the CHIEF pathway and risk of colorectal cancer.

Slattery ML, Wolff RK, Lundgreen A.

Carcinogenesis. 2015 Jan;36(1):49-59. doi: 10.1093/carcin/bgu213. Epub 2014 Oct 20.

9.

An analysis of genetic factors related to risk of inflammatory bowel disease and colon cancer.

Ryan BM, Wolff RK, Valeri N, Khan M, Robinson D, Paone A, Bowman ED, Lundgreen A, Caan B, Potter J, Brown D, Croce C, Slattery ML, Harris CC.

Cancer Epidemiol. 2014 Oct;38(5):583-90. doi: 10.1016/j.canep.2014.07.003. Epub 2014 Aug 15.

PMID:
25132422
10.

CYP19A1 single nucleotide polymorphism associations with CYP19A1, NFκB1, and IL6 gene expression in human normal colon and normal liver samples.

Penney RB, Lundgreen A, Yao-Borengasser A, Edavana VK, Williams S, Dhakal I, Wolff RK, Kadlubar S, Slattery ML.

Pharmgenomics Pers Med. 2014 Jul 14;7:163-71. doi: 10.2147/PGPM.S62238. eCollection 2014.

11.

Genetic variation in the JAK/STAT/SOCS signaling pathway influences breast cancer-specific mortality through interaction with cigarette smoking and use of aspirin/NSAIDs: the Breast Cancer Health Disparities Study.

Slattery ML, Lundgreen A, Hines LM, Torres-Mejia G, Wolff RK, Stern MC, John EM.

Breast Cancer Res Treat. 2014 Aug;147(1):145-58. doi: 10.1007/s10549-014-3071-y. Epub 2014 Aug 8.

12.

Diet and lifestyle factors interact with MAPK genes to influence survival: the Breast Cancer Health Disparities Study.

Slattery ML, Hines LH, Lundgreen A, Baumgartner KB, Wolff RK, Stern MC, John EM.

Cancer Causes Control. 2014 Sep;25(9):1211-25. doi: 10.1007/s10552-014-0426-y. Epub 2014 Jul 4.

13.

Influence of CHIEF pathway genes on gene expression: a pathway approach to functionality.

Slattery ML, Lundgreen A, Mullany LE, Penney RB, Wolff RK.

Int J Mol Epidemiol Genet. 2014 May 29;5(2):100-11. eCollection 2014.

14.

The influence of genetic ancestry and ethnicity on breast cancer survival associated with genetic variation in the TGF-β-signaling pathway: The Breast Cancer Health Disparities Study.

Slattery ML, Lundgreen A, Stern MC, Hines L, Wolff RK, Giuliano AR, Baumgartner KB, John EM.

Cancer Causes Control. 2014 Mar;25(3):293-307. doi: 10.1007/s10552-013-0331-9. Epub 2013 Dec 12.

15.

SEPP1 influences breast cancer risk among women with greater native american ancestry: the breast cancer health disparities study.

Pellatt AJ, Wolff RK, John EM, Torres-Mejia G, Hines LM, Baumgartner KB, Giuliano AR, Lundgreen A, Slattery ML.

PLoS One. 2013 Nov 20;8(11):e80554. doi: 10.1371/journal.pone.0080554. eCollection 2013.

16.

Lack of correlation between in silico projection of function and quantitative real-time PCR-determined gene expression levels in colon tissue.

Penney RB, Lundgreen A, Yao-Borengasser A, Koroth-Edavana V, Williams S, Wolff R, Slattery ML, Kadlubar S.

Pharmgenomics Pers Med. 2013 Sep 9;6:99-103. doi: 10.2147/PGPM.S49199. eCollection 2013.

17.

Associations with growth factor genes (FGF1, FGF2, PDGFB, FGFR2, NRG2, EGF, ERBB2) with breast cancer risk and survival: the Breast Cancer Health Disparities Study.

Slattery ML, John EM, Stern MC, Herrick J, Lundgreen A, Giuliano AR, Hines L, Baumgartner KB, Torres-Mejia G, Wolff RK.

Breast Cancer Res Treat. 2013 Aug;140(3):587-601. doi: 10.1007/s10549-013-2644-5. Epub 2013 Aug 3.

18.

Dietary influence on MAPK-signaling pathways and risk of colon and rectal cancer.

Slattery ML, Lundgreen A, Wolff RK.

Nutr Cancer. 2013;65(5):729-38. doi: 10.1080/01635581.2013.795599.

19.

Angiogenesis genes, dietary oxidative balance and breast cancer risk and progression: the Breast Cancer Health Disparities Study.

Slattery ML, John EM, Torres-Mejia G, Lundgreen A, Lewinger JP, Stern MC, Hines L, Baumgartner KB, Giuliano AR, Wolff RK.

Int J Cancer. 2014 Feb 1;134(3):629-44. doi: 10.1002/ijc.28377. Epub 2013 Aug 9.

20.

VEGFA, FLT1, KDR and colorectal cancer: assessment of disease risk, tumor molecular phenotype, and survival.

Slattery ML, Lundgreen A, Wolff RK.

Mol Carcinog. 2014 Feb;53 Suppl 1:E140-50. doi: 10.1002/mc.22058. Epub 2013 Jun 21.

PMID:
23794399
21.

Matrix metalloproteinase genes are associated with breast cancer risk and survival: the Breast Cancer Health Disparities Study.

Slattery ML, John E, Torres-Mejia G, Stern M, Lundgreen A, Hines L, Giuliano A, Baumgartner K, Herrick J, Wolff RK.

PLoS One. 2013 May 16;8(5):e63165. doi: 10.1371/journal.pone.0063165. Print 2013.

22.

Telomere length, telomere-related genes, and breast cancer risk: the breast cancer health disparities study.

Pellatt AJ, Wolff RK, Torres-Mejia G, John EM, Herrick JS, Lundgreen A, Baumgartner KB, Giuliano AR, Hines LM, Fejerman L, Cawthon R, Slattery ML.

Genes Chromosomes Cancer. 2013 Jul;52(7):595-609. doi: 10.1002/gcc.22056. Epub 2013 Apr 30.

23.

Genetic and lifestyle influence on telomere length and subsequent risk of colon cancer in a case control study.

Pellatt AJ, Wolff RK, Lundgreen A, Cawthon R, Slattery ML.

Int J Mol Epidemiol Genet. 2012;3(3):184-94. Epub 2012 Aug 31.

24.

MAP kinase genes and colon and rectal cancer.

Slattery ML, Lundgreen A, Wolff RK.

Carcinogenesis. 2012 Dec;33(12):2398-408. doi: 10.1093/carcin/bgs305. Epub 2012 Oct 1.

25.

PTGS1, PTGS2, ALOX5, ALOX12, ALOX15, and FLAP SNPs: interaction with fatty acids in colon cancer and rectal cancer.

Habermann N, Ulrich CM, Lundgreen A, Makar KW, Poole EM, Caan B, Kulmacz R, Whitton J, Galbraith R, Potter JD, Slattery ML.

Genes Nutr. 2013 Jan;8(1):115-26. doi: 10.1007/s12263-012-0302-x. Epub 2012 Jun 8.

26.

Interleukin genes and associations with colon and rectal cancer risk and overall survival.

Bondurant KL, Lundgreen A, Herrick JS, Kadlubar S, Wolff RK, Slattery ML.

Int J Cancer. 2013 Feb 15;132(4):905-15. doi: 10.1002/ijc.27660. Epub 2012 Jun 26.

27.

Genetic variation in selenoprotein genes, lifestyle, and risk of colon and rectal cancer.

Slattery ML, Lundgreen A, Welbourn B, Corcoran C, Wolff RK.

PLoS One. 2012;7(5):e37312. doi: 10.1371/journal.pone.0037312. Epub 2012 May 17.

28.

Genetic variation in genes involved in hormones, inflammation and energetic factors and breast cancer risk in an admixed population.

Slattery ML, John EM, Torres-Mejia G, Lundgreen A, Herrick JS, Baumgartner KB, Hines LM, Stern MC, Wolff RK.

Carcinogenesis. 2012 Aug;33(8):1512-21. doi: 10.1093/carcin/bgs163. Epub 2012 May 4.

29.

Oxidative balance and colon and rectal cancer: interaction of lifestyle factors and genes.

Slattery ML, Lundgreen A, Welbourn B, Wolff RK, Corcoran C.

Mutat Res. 2012 Jun 1;734(1-2):30-40. doi: 10.1016/j.mrfmmm.2012.04.002. Epub 2012 Apr 15.

30.

Genetic variation in the transforming growth factor-β-signaling pathway, lifestyle factors, and risk of colon or rectal cancer.

Slattery ML, Lundgreen A, Wolff RK, Herrick JS, Caan BJ.

Dis Colon Rectum. 2012 May;55(5):532-40. doi: 10.1097/DCR.0b013e31824b5feb.

31.

TERT's role in colorectal carcinogenesis.

Pellatt AJ, Wolff RK, Herrick J, Lundgreen A, Slattery ML.

Mol Carcinog. 2013 Jul;52(7):507-13. doi: 10.1002/mc.21885. Epub 2012 Feb 21.

32.

Tumor necrosis factor-related genes and colon and rectal cancer.

Slattery ML, Lundgreen A, Bondurant KL, Wolff RK.

Int J Mol Epidemiol Genet. 2011;2(4):328-38. Epub 2011 Oct 20.

33.

JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.

Slattery ML, Lundgreen A, Kadlubar SA, Bondurant KL, Wolff RK.

Mol Carcinog. 2013 Feb;52(2):155-66. doi: 10.1002/mc.21841. Epub 2011 Nov 28.

34.

Diet and colorectal cancer: analysis of a candidate pathway using SNPS, haplotypes, and multi-gene assessment.

Slattery ML, Lundgreen A, Herrick JS, Caan BJ, Potter JD, Wolff RK.

Nutr Cancer. 2011 Nov;63(8):1226-34. doi: 10.1080/01635581.2011.607545. Epub 2011 Oct 14.

35.

Interferon-signaling pathway: associations with colon and rectal cancer risk and subsequent survival.

Slattery ML, Lundgreen A, Bondurant KL, Wolff RK.

Carcinogenesis. 2011 Nov;32(11):1660-7. doi: 10.1093/carcin/bgr189. Epub 2011 Aug 22.

36.

Variation in the CYP19A1 gene and risk of colon and rectal cancer.

Slattery ML, Lundgreen A, Herrick JS, Kadlubar S, Caan BJ, Potter JD, Wolff RK.

Cancer Causes Control. 2011 Jul;22(7):955-63. doi: 10.1007/s10552-011-9768-x. Epub 2011 Apr 11.

37.

Genetic variation in bone morphogenetic protein and colon and rectal cancer.

Slattery ML, Lundgreen A, Herrick JS, Kadlubar S, Caan BJ, Potter JD, Wolff RK.

Int J Cancer. 2012 Feb 1;130(3):653-64. doi: 10.1002/ijc.26047. Epub 2011 Apr 27.

38.

Genetic variation in the transforming growth factor-β signaling pathway and survival after diagnosis with colon and rectal cancer.

Slattery ML, Lundgreen A, Herrick JS, Wolff RK, Caan BJ.

Cancer. 2011 Sep 15;117(18):4175-83. doi: 10.1002/cncr.26018. Epub 2011 Mar 1.

39.

Associations between genetic variation in RUNX1, RUNX2, RUNX3, MAPK1 and eIF4E and riskof colon and rectal cancer: additional support for a TGF-β-signaling pathway.

Slattery ML, Lundgreen A, Herrick JS, Caan BJ, Potter JD, Wolff RK.

Carcinogenesis. 2011 Mar;32(3):318-26. doi: 10.1093/carcin/bgq245. Epub 2010 Nov 18.

40.

Genetic variation in the TGF-β signaling pathway and colon and rectal cancer risk.

Slattery ML, Herrick JS, Lundgreen A, Wolff RK.

Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):57-69. doi: 10.1158/1055-9965.EPI-10-0843. Epub 2010 Nov 10.

41.

Genetic variation in RPS6KA1, RPS6KA2, RPS6KB1, RPS6KB2, and PDK1 and risk of colon or rectal cancer.

Slattery ML, Lundgreen A, Herrick JS, Wolff RK.

Mutat Res. 2011 Jan 10;706(1-2):13-20. doi: 10.1016/j.mrfmmm.2010.10.005. Epub 2010 Oct 28.

42.

Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1.

Slattery ML, Herrick JS, Lundgreen A, Fitzpatrick FA, Curtin K, Wolff RK.

Carcinogenesis. 2010 Sep;31(9):1604-11. doi: 10.1093/carcin/bgq142. Epub 2010 Jul 9.

Supplemental Content

Loading ...
Support Center